May 16 |
Plus Therapeutics, Inc. (PSTV) Q1 2024 Earnings Call Transcript
|
May 15 |
Plus Therapeutics GAAP EPS of -$0.75 beats by $0.34, revenue of $1.67M misses by $0.02M
|
May 15 |
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
May 14 |
Plus Therapeutics Q1 2024 Earnings Preview
|
May 13 |
Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024
|
May 8 |
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
|
May 6 |
Plus Therapeutics looks to raise $18 million through private placement
|
May 6 |
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
|
Apr 22 |
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
|
Apr 22 |
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
|